Abstract
Contents of 52 trace elements in intact prostate of 64 apparently healthy 13–60-year-old men (mean age 36.5 years) were investigated by inductively coupled plasma mass spectrometry. Mean values (M ± SΕΜ) for mass fraction (in milligrams per kilogram, on dry-weight basis) of trace elements were as follows: Ag 0.041 ± 0.005, Al 36 ± 4, Au 0.0039 ± 0.0007, B 0.97 ± 0.13, Be 0.00099 ± 0.00006, Bi 0.021 ± 0.008, Br 29 ± 3, Cd 0.78 ± 0.09, Ce 0.028 ± 0.004, Co 0.035 ± 0.003, Cs 0.034 ± 0.003, Dy 0.0031 ± 0.0005, Er 0.0018 ± 0.0004, Gd 0.0030 ± 0.0005, Hg 0.046 ± 0.006, Ho 0.00056 ± 0.00008, La 0.074 ± 0.015, Li 0.040 ± 0.004, Mn 1.53 ± 0.09, Mo 0.30 ± 0.03, Nb 0.0051 ± 0.0009, Nd 0.013 ± 0.002, Ni 4.3 ± 0.7, Pb 1.8 ± 0.4, Pr 0.0033 ± 0.0004, Rb 15.9 ± 0.6, Sb 0.040 ± 0.005, Se 0.73 ± 0.03, Sm 0.0027 ± 0.0004, Sn 0.25 ± 0.05, Tb 0.00043 ± 0.00009, Th 0.0024 ± 0.0005, Tl 0.0014 ± 0.0001, Tm 0.00030 ± 0.00006, U 0.0049 ± 0.0014, Y 0.019 ± 0.003, Yb 0.0015 ± 0.0002, Zn 782 ± 97, and Zr 0.044 ± 0.009, respectively. The upper limit of mean contents of As, Cr, Eu, Ga, Hf, Ir, Lu, Pd, Pt, Re, Ta, and Ti were the following: As ≤0.018, Cr ≤0.64, Eu ≤0.0006, Ga ≤0.08, Hf ≤0.02, Ir ≤0.0004, Lu ≤0.00028, Pd ≤0.007, Pt ≤0.0009, Re ≤0.0015, Ta ≤0.005, and Ti ≤2.6. In all prostate samples, the content of Te was under detection limit (<0.003). Additionally, ratios of the Zn content to other trace element contents as well as correlations between Zn and trace elements were calculated. Our data indicate that the human prostate accumulates such trace elements as Al, Au, B, Br, Cd, Cr, Ga, Li, Mn, Ni, Pb, U, and Zn. No special relationship between Zn and other trace elements was found.
Similar content being viewed by others
References
Oliver SE, Gunnell D, Donovan JL (2000) Comparison of trends in prostate-cancer mortality in England and Wales and the USA. Lancet 355:1788–1789
Kumar RJ, Barqawi AB, Crawford ED (2004) Epidemiology of prostate cancer. Business Briefing, US Oncology Review, pp 1–6
Pischon T, Boeing H, Weikert S, Allen N, Key T, Johnsen NF, Tjonneland A, Severinsen MT, Overvad K, Rohrmann S, Kaaks R, Trichopoulou A, Zoi G, Trichopoulos D, Pala V, Palli D, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, May A, Manjer J, Wallström P, Stattin P, Hallmans G, Buckland G, Larranaga N, Chirlaque MD, Martinez C, Redondo Cornejo ML, Ardanaz E, Bingham S, Khaw K-T, Rinaldi S, Slimani N, Jenab M, Riboli E (2008) Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev 17:3252–3261
Cohen LA (2002) Nutrition and prostate cancer: a review. Ann NY Acad Sci 963:148–155
Jones BA, Liu W-L, Araujo AB, Kasl SV, Silvera SN, Soler-Vilaґ H, Curnen MGM, Dubrow R (2008) Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomark Prev 17:2825–2834
Van Patten CL, De Boer JG, Tomlinson Guns ES (2008) Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. J Urol 180:2314–2322
Thomas JA (1999) Diet, micronutrients, and the prostate gland. Nutr Rev 57:95–103
Giovanucci E, Ascherio A, Rimm E, Stampfer MJ, Colditz GA (1995) Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87:1767–1776
Blumenfeld AJ, Fleshner N, Casselman B, Trachtenberg J (2000) Nutritional aspects of prostate cancer: a review. Can J Urol 7:927–935
Yamada K, Araki S, Tamura M, Saka Y, Takahashi M, Kashihara H, Kono S (2000) Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer 89:259–264
Gray MA, Centeno JA, Slaney DP, Ejnik JW, Todorov T, Nacey JN (2005) Environmental exposure to trace elements and prostate cancer in three New Zealand ethnic groups. Int J Environ Res Public Health 2:374–384
Rebbeck TR (2006) Conquering cancer disparities: new opportunities for cancer epidemiology, biomarker, and prevention research. Cancer Epidemiol Biomark Prev 15:1569–1571
Zaichick V (2006) Medical elementology as a new scientific discipline. J Radioanal Nucl Chem 269:303–309
Ide-Ektessabi A, Fujisawa F, Sugiruma K, Kitamura Y, Gotoh A (2002) Quantitative analysis of zinc in prostate cancer tissue using synchrotron radiation microbeams. X-Ray Spectrom 31:7–11
Nayak SB, Bhat VR, Upadhyay D, Udupa SL (2003) Copper and ceruloplasmin status in serum of prostate and colon cancer patients. Indian J Physiol Pharmacol 47:108–110
Aydin A, Arsova-Sarafinovska Z, Sayal A, Eken A, Erdem O, Erten K, Ozgok Y, Dimovski A (2006) Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem 39:176–179
Guntupalli JNR, Padala S, Gummuluri AVRM, Muktineni RK, Byreddy SR, Sreerama L, Kedarisetti PC, Angalakuduru DP, Satti BR, Venkatathri V, Pullela VBRL, Gavarasana S (2007) Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particle-induced X-ray emission technique. Eur J Cancer Prev 16:108–115
Silvera SAN, Rohan TE (2007) Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control 18:7–27
Kiziler AR, Aydemir B, Guzel S, Alici B, Ataus S, Tuna MB, Durak H, Kilic M (2010) May the level and ratio changes of trace elements be utilized in identification of disease progression and grade in prostatic cancer? Trace Elem Electrolytes 27:65–72
Oldereid NB, Thomassen Y, Attramadal A, Olaisen B, Purvis K (1993) Concentrations of lead, cadmium and zinc in the tissues of reproductive organs of men. J Reprod Fertil 99:421–425
Waalkes MP, Rehm S (1994) Cadmium and prostate cancer. J Toxicol Environ Health 43:251–269
Clark LC, Marshall JR (2001) Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia. Urology 57(4 Suppl 1):185–187
Nelson MA, Reid ME, Duffield-Lillico AJ, Marshall JR (2002) Prostate cancer and selenium. Urol Clin North Am 29:67–70
Willis MS, Wians FH (2003) The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta 330:57–83
Nyman DW, Stratton SM, Kopplin MJ, Dalkin BL, Nagle RB, Gandolfi JA (2004) Selenium and selenomethionine levels in prostate cancer patients. Cancer Detect Prev 28:8–16
Sapota A, Daragó A, Taczalski J, Kilanowicz A (2009) Disturbed homeostasis of zinc and other essential elements in the prostate gland dependent on the character of pathological lesions. Biometals 22:1041–1049
Sarafanov AG, Todorov TI, Centeno JA, Macias V, Gao W, Liang W-M, Beam C, Gray MA, Kajdacsy-Balla AA (2011) Prostate cancer outcome and tissue levels of metal ions. Prostate 71:1231–1238
Guzel S, Kiziler L, Aydemir B, Alici B, Ataus S, Aksu A, Durak H (2012) Association of Pb, Cd, and Se Concentrations and oxidative damage-related markers in different grades of prostate carcinoma. Biol Trace Elem Res 145:23–32
Stohs SJ, Baggihi D (1995) Oxidative mechanisms in the toxicity of metal ions. Free Radic Med 18:321–336
Witkiewicz-Kucharczyk A, Bal W (2006) Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol Lett 162:29–42
Beyersmann D, Hartwig A (2008) Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch Toxicol 82:493–512
Salnikow K, Zhitkovich A (2008) Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 21:28–44
Martinez-Zamudio R, Ha HC (2011) Environmental epigenetics in metal exposure. Epigenetics 6:820–827
Coleman JE (1992) Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem 61:897–946
Zaichick V, Sviridova T, Zaichick S (1997) Zinc in human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 29:565–574
Zaichick V, Zaichick S (1999) Role of zinc in prostate cancerogenesis. In: Mengen und Spurenelemente, 19 Arbeitstagung. Friedrich-Schiller-Universitat, Jena, 1999, pp 104–115
Zaichick V (2004) INAA and EDXRF applications in the age dynamics assessment of Zn content and distribution in the normal human prostate. J Radioanal Nucl Chem 262:229–234
Costello LC, Franklin RB (1998) Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 35:285–296
Zaichick S, Zaichick V (2012) Trace elements of normal, benign hypertrophic and cancerous tissues of the human prostate gland investigated by neutron activation analysis. Appl Radiat Isot 70:81–87
Zaichick V, Nosenko S, Moskvina I (2012) The effect of age on 12 chemical element contents in intact prostate of adult men investigated by inductively coupled plasma atomic emission spectrometry. Biol Trace Elem Res. doi:10.1007/S12011-011-9294-4
Sarafanov AG, Todorov TI, Kajdacsy-Balla A, Gray MA, Macias V, Centeno JA (2008) Analysis of iron, zinc, selenium and cadmium in paraffin-embedded prostate tissue specimens using inductively coupled plasma mass-spectrometry. J Trace Elem Med Biol 22:305–314
Tipton IH, Cook MJ (1963) Trace elements in human tissue. Part II. Adult subjects from the United States. Health Phys 9:103–145
Tipton JH, Steiner RL, Foland WD, Mueller J, Stanley M (1954) USAEC-ORNL-Report-CF-54-12-66
Stitch SR (1957) Trace elements in human tissue. I. A semi-quantitative spectrographic survey. Biochem J 67:97–103
Liebscher K, Smith H (1968) Essential and nonessential trace elements. A method of determining whether an element is essential or nonessential in human tissue. Arch Environ Health 17:882–891
Kubo H, Hashimoto S, Ishibashi A, Chiba R, Yokota H (1976) Simultaneous determinations of Fe, Cu, Zn, and Br concentrations in human tissue sections. Med Phys 3:204–209
Forssen A (1972) Inorganic elements in the human body. I. occurrence of Ba, Br, Ca, Cd, Cs, Cu, K, Mn, Ni, Sn, Sr, Y and Zn in the human body. Annales medicinae Experimentalis et Biologie (Finland) 50:99–162
Schöpfer J, Drasch G, Schrauzer GN (2010) Selenium and cadmium levels and ratios in prostates, livers, and kidneys of nonsmokers and smokers. Biol Trace Elem Res 134:180–187
Ogunlewe JO, Osegbe DN (1989) Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer 63:1388–1392
Yamagata N (1962) The concentration of common cesium and rubidium in human body. J Radiat Res 3:9–30
Soman SD, Joseph KT, Raut SJ, Mulay GD, Parameswaran M, Pandey VK (1970) Studies of major and trace element content in human tissues. Health Phys 19:641–656
Koch HJ, Smith ER (1956) The determination of copper and zinc in normal and pathologic human thyroid tissue. J Clin Endocrinol 16:123–129
Weinig E, Zink P (1967) Über die quantitative massenspektrometrische Bestimmung des normalen Thallium-Geehalts inmenschlichen Organismus. Archiv für Toxikologie 22:255–274
Höffken B, Rausch-Stroomann JG (1969) A study of the metabolism of zinc its metalloenzymes in diabetes mellitus. Z Klin Chem Klin Biochem 7:4–7
Anspaugh LR, Robinson WL, Martin WH, Lowe OA (1973) Compilation of published information on elemental concentrations in human organs in both normal and diseased states. No. UCRL-51013Pt. 1971-1973, pp. 1–4
Jafa A, Mahendra NM, Chowdhury AR, Kamboj VP (1980) Trace elements in prostatic tissue and plasma in prostatic diseases of man. Indian J Cancer 17:34–37
Györkey F, Min K-W, Huff JA, Györkey P (1967) Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. Cancer Res 27:1349–1353
Saltzman BE, Gross SB, Yeager DW, Meiners BG, Gartside PS (1990) Total body burdens and tissue concentrations of lead, cadmium, copper, zinc, and ach in 55 human cadavers. Environ Res 52:126–145
Iyengar GV, Kollmer WE, Bowen HGM (1978) The elemental composition of human tissues and body fluids. A compilation of values for adults, Verlag Chemie, Weinheim, 151 p
Iyengar GV (1998) Reevaluation of the trace element content in reference men. Radiat Phys Chem 51:545–560
Feustel A, Wennrich R, Steiniger D, Klauss P (1982) Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH). Urol Res 10:301–303
Brys M, Nawrocka AD, Miekos E, Zydek C, Foksinski M, Berecki A, Krajewska W (1997) Zinc and cadmium analysis in human prostate neoplasmas. Biol Trace Elem Res 59:145–152
Acknowledgments
The authors are grateful to Prof. A. A. Zhavoronkov of Institute of Human Morphology, Russian Academy of Medical Sciences, Moscow, for supplying prostate samples, and they acknowledge the support of the Presidium of Russian Academy of Sciences, program for basic research “Creation and improvement of methods of chemical analysis, and investigation of substances and material structure.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zaichick, S., Zaichick, V., Nosenko, S. et al. Mass Fractions of 52 Trace Elements and Zinc/Trace Element Content Ratios in Intact Human Prostates Investigated by Inductively Coupled Plasma Mass Spectrometry. Biol Trace Elem Res 149, 171–183 (2012). https://doi.org/10.1007/s12011-012-9427-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-012-9427-4